相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K

下一代测序作为一种有价值的工具,用于在晚期NSCLC患者的突变谱

Ioana Iurca1,2, Ecaterina Isakescu1, Laura Ancuta Pop1

  • 1Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Medicine and pharmacy reports
|September 5, 2024
PubMed
概括

这项研究分析了晚期肺癌患者的血液DNA,以确定突变. 10名患者中有9名患有TP53突变,突出的是用于个性化癌症治疗的液体活检.

关键词:
在NSCLCLC中,我们可以看到NSCLCLC.这是下一代测序.生物标志物 生物标志物

更多相关视频

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.7K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.5K